BioMarin Pharmaceutical
BMRN
#1907
Rank
NZ$17.75 B
Marketcap
NZ$92.44
Share price
-0.78%
Change (1 day)
-17.82%
Change (1 year)

BioMarin Pharmaceutical (BMRN) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$1.04 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's total debt is NZ$1.04 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

BioMarin Pharmaceutical - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$1.06 B-38.32%
2023-12-31NZ$1.73 B0.61%
2022-12-31NZ$1.72 B7.96%
2021-12-31NZ$1.59 B5.89%
2020-12-31NZ$1.50 B18.13%
2019-12-31NZ$1.27 B3%
2018-12-31NZ$1.23 B-25.14%
2017-12-31NZ$1.65 B67.66%
2016-12-31NZ$0.98 B1.93%
2015-12-31NZ$0.96 B17.93%
2014-12-31NZ$0.82 B2.86%
2013-12-31NZ$0.79 B88.46%
2012-12-31NZ$0.42 B-5.16%
2011-12-31NZ$0.44 B-8.79%
2010-12-31NZ$0.48 B-28.5%
2009-12-31NZ$0.68 B-30.06%
2008-12-31NZ$0.97 B50.69%
2007-12-31NZ$0.64 B98.26%
2006-12-31NZ$0.32 B-0.18%
2005-12-31NZ$0.32 B-13.56%
2004-12-31NZ$0.37 B97.39%
2003-12-31NZ$0.19 B
2001-12-31NZ$13.37 M7038.59%
2000-12-31NZ$0.18 M-11.82%
1999-12-31NZ$0.21 M11.94%
1998-12-31NZ$0.18 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Ultragenyx Pharmaceutical
RARE
NZ$58.56 M-94.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
NZ$44 M-95.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$0.53 B-49.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$44.19 B 4,125.35%๐Ÿ‡ซ๐Ÿ‡ท France
Amicus Therapeutics
FOLD
NZ$0.76 B-26.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
NZ$5 M-99.52%๐Ÿ‡บ๐Ÿ‡ธ USA